Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture
- 1.1k Downloads
The human female breast gland is composed of branching epithelial ducts that extend from the nipple towards the terminal duct lobular units (TDLUs), which are the functional, milk-producing units of the gland and the site of origin of most breast cancers. The epithelium of ducts and TDLUs is composed of an inner layer of polarized luminal epithelial cells and an outer layer of contractile myoepithelial cells, separated from the vascular-rich stroma by a basement membrane. The luminal- and myoepithelial cells share an origin and in recent years, there has been increasing understanding of how these cell types interact and how they contribute to breast cancer. Accumulating evidence links stem/or progenitor cells in the mammary/breast gland to breast cancer. In that regard, much knowledge has been gained from studies in mice due to specific strains that have allowed for gene knock out/in studies and lineage tracing of cellular fates. However, there is a large histologic difference between the human female breast gland and the mouse mammary gland that necessitates that research needs to be done on human material where primary cultures are important due to their close relation to the tissue of origin. However, due to difficulties of long-term cultures and lack of access to material, human cell lines are of great importance to bridge the gap between studies on mouse mammary gland and human primary breast cells. In this review, we describe D492, a breast epithelial progenitor cell line that can generate both luminal- and myoepithelial cells in culture, and in 3D culture it forms branching ducts similar to TDLUs. We have applied D492 and its daughter cell lines to explore cellular and molecular mechanisms of branching morphogenesis and cellular plasticity including EMT and MET. In addition to discussing the application of D492 in studying normal morphogenesis, we will also discuss how this cell line has been used to study breast cancer progression.
KeywordsBreast stem cells D492 Breast morphogenesis EMT MET microRNA HER2 Breast cancer
The Histology of the Human Breast Gland
Differences Between the Human and Mouse Mammary Glands
In vivo models have contributed enormously to our knowledge of breast biology and cancer [3, 14, 15]. Knock-in and knock-out mutations have unraveled the functions of important tumor suppressors and or oncogenes and hundreds of mouse strains are available that capture phenotypic changes related to these gene interventions [14, 16]. While all this knowledge in terms of mouse mammary gland biology exist, it is important to acknowledge, that there are major differences between mouse and human mammary glands. This is due to histological differences between these two species. While both species’ mammary glands are embedded in adipose tissue, the mouse gland presents with very limited amount of collagenous stroma. The human female breast gland on the other hand is embedded in cellular rich intralobular stroma containing endothelial cells, fibroblasts and immune cells surrounded by interlobular collagen rich stroma . Obviously, the species exhibit vast differences in life span (1 year compared to approx. 80 in humans), and therefore exhibit different sensitivity to cancerogenic insults [18, 19]. It is increasingly evident that breast cancer progression is an excellent example of Darwinian evolutionary principals, where cells that proliferate faster, survive better and adapt more proficiently to challenges in the environment. A one-year lifespan as is the case for the mouse is hardly a perfect model for recapitulating those parameters. Modeling human breast morphogenesis and cancer progression in vitro is therefore an important tool to explore molecular and cellular mechanisms that drive these phenotypic events. It is of great importance that we advance the understanding of how the human breast gland develops by improving cell culture models that recapture in vivo like morphogenesis. This will ultimately contribute to a better understanding of breast morphogenesis in normal conditions and in neoplasia.
Three-Dimensional Cell Culture to Explore Mammary Gland Morphogenesis and Cancer
There is growing interest in three-dimensional (3D) culture of human tissue due to the fact that conditions created in 3D more closely mimic in vivo conditions than culturing cells in conventional two dimensional (2D) monolayer culture where hiostoarchitecture is lost . For decades, mammary epithelial cells have been cultured in 3D context and this work has been pioneered by several excellent scientists (reviewed in Simian and Bissell ). Emmerman and Pitelka demonstrated in 1977 that differentiated mammary cells could be cultured on floating collagen . It was further shown that mammary epithelial cells were able to polarize and form milk protein when cultured on floating collagen [23, 24]. In addition, it has been shown in collagen culture albeit not floating gel that normal human breast myoepithelial cells regulate polarization of luminal epithelial cells, which is a function lacking in cancer-derived myoepithelial cells . Recently, the group of Christina Scheel, succeeded in recapitulating branching morphogenesis in floating collagen gels using primary human breast epithelial cells [25, 26]. Another extracellular matrix that has been widely used to study breast/mammary gland morphogenesis and cancer is reconstituted basement membrane matrix (rBM) commonly referred to as Matrigel [27, 28, 29]. rBM has been successfully used to study polarization of normal breast epithelial cells and lack thereof in cancer cells [30, 31]. With improved cell culture methods such as better cell culture media, it is now possible to grow breast cancer-derived organoids for longer periods in 3D culture . This is of great importance, since this enables drug screening using cancer-derived organoids, which forms a platform for future precision cancer medicine. In addition to collagen and rBM, researchers have begun testing new chemically defined matrices to grow breast epithelial cells. Recently, Sokol et al. described chemically defined hydrogel to cultivate breast epithelial cells. Under these cell culture conditions, primary breast epithelial cells self-organize into branching ducts with spatially correctly located luminal and basal cells . Collectively, cell culture techniques have been improving through the years allowing breast epithelial cells to be cultivated in an environment that supports in vivo-like morphogenesis seen in normal and malignant mammary glands.
Cellular Origin of the D492 Cell Line
The search for the true human breast epithelial stem cells has been a long journey and a matter of debate within the research field for many years and still is. We have witnessed great success in cell lineage tracing and hunt for stem cells in the mouse mammary gland, where numbers of papers have demonstrated the presence of stem and progenitor cells [34, 35, 36]. For obvious reasons the linage tracing of breast epithelial stem/progenitor cells in vivo in humans is not possible. Instead, studies on human mammary gland rely on tissue from biopsies such as reduction mammoplasties and on established cell lines. Reduction mammoplasties have been a great resource for cell biologists studying breast development and breast cancer due to the large amount of material available from each biopsy and due to the normal histology of the tissue. This unique material is rich in cellular components both epithelial and stromal cells. Pioneering work by Mina Bissell, Ole William Petersen and others has paved the way for culture of human primary cells from tissue derived from reduction mammoplasty [8, 31, 37]. Isolation protocols for different cell types and subsequent improvements of cell culture conditions for the last two decades have accelerated the search for breast epithelial stem cells and increased the knowledge on how the microenvironment regulates cell fate decision [7, 17, 38]. Initial separation of luminal epithelial- and myoepithelial cells and subsequent findings that subpopulation of luminal epithelial cells could give rise to myoepithelial cells was an important step . In a following paper, it was demonstrated that MUC1 negative and EpCAM positive suprabasal cells had stem cell properties. Isolated MUC1 negative and EpCAM positive suprabasal cells were immortalized using retroviral constructs containing the E6 and E7 oncogenes from the human papilloma virus 16. This cell line was initially referred to as suprabasal cell line [5, 6] and later renamed as D492 . D492 has stem cell properties as measured by its ability to form luminal- and myoepithelial cells in monolayer culture and to generate branching colonies akin to TDLUs when cultured in three-dimensional reconstituted basement membrane (3D-rBM) (Fig. 1). Interestingly, co-expression of both luminal and myoepithelial keratins (K14 and K19) is found in subpopulations of D492 cells. Co-expression of these two keratins is also found in suprabasal cells of the breast gland in situ [6, 40] and has been associated with stem cell properties. Although, D492 cells show stem cell properties by giving rise to both luminal- and myoepithelial cells they are not able to give rise to estrogen receptor (ER) positive luminal epithelial cells. It has been a major problem for decades to culture ER positive normal breast epithelial cells. The only ER positive cell lines available are derived from breast cancer such as MCF-7 and T47-D [41, 42]. Overcoming this problem is important due to the fact that 70% of breast cancers are ER positive and it is currently unknown if this type of breast cancer originates in ER positive cells or if its expression is turned on during cancer progression. Most recently, an important milestone was reached, when Fridriksdottir et al. succeeded in expanding ER positive primary cells in culture. This was achieved by inhibiting the TGFβ receptor with two small molecule inhibitors and by adaption to specific cell culture media . In a following paper, the same group succeeded in generating immortalized normal-derived ER positive cell line referred to as iHBECERpos . Thus, the iHBECERpos cell line and D492 are important normal-derived breast epithelial cell lines that can be highly useful to study normal breast morphogenesis and to contribute to better understanding of ER positive and ER negative breast cancer, respectively.
Application of D492 to Explore EMT and Branching Morphogenesis
Functional Role of MicroRNAs in EMT and MET
Noncoding RNAs (ncRNAs) have in recent years demonstrated the complexity of biological processes that previously were only considered to be regulated by coding genes. MicroRNAs (miRNAs) a well-known class of ncRNAs are involved in most biological processes both in health and diseases [52, 53]. Among those are epithelial to mesenchymal transition (EMT) and its reverse process mesenchymal to epithelial transition (MET) important processes involved in organ development but are hijacked in some forms of cancer . We have applied D492 and D492M to study the role of miRNAs in EMT and MET. Microarray analysis revealed profound changes in miRNA expression between D492 and D492M . The miR-200 family, miR-203a and miR-205 were among the most downregulated miRNAs in D492M. These miRNAs have been described being highly expressed in epithelial tissue and loss of expression has been shown to occur during EMT [55, 56, 57]. The miR-200 family is composed of five miRNAs (mir-200a, mir-200b, miR-200c, miR-141 and miR-429). In humans, miR-200c and miR-141 are located on the same cluster on chromosome 12. They share a promoter but their seeding sequence is different. In D492M, overexpression of miR-200c-141 induced MET, but only towards the luminal epithelial phenotype. D492MmiR-200c-141 expresses the epithelial marker E-cadherin and luminal epithelial markers such as EpCAM and K19. However, the expression of myoepithelial markers such as P-cadherin, K14, K5/6, K17 and the transcription factor p63 were not re-induced in the cell line. In 3D culture, D492MmiR-200c-141 retains epithelial phenotype, but does not form branching colonies like D492. In addition, constitutive expression of miR-200c-141 in D492 does not affect its ability to form branching colonies in 3D culture, it does however, prevent endothelial induced EMT. This means that while miR-200c-141 governs epithelial phenotype in the cell line, its downregulation is not necessary for the cells to carry out branching morphogenesis, which involves partial EMT.
Collectively, the differences in expression of numbers of miRNAs between D492 and D492M makes these isogenic cell lines highly useful to explore miRNA functions in breast epithelial morphogenesis, EMT and MET. So far, we have only been looking into a small selection of miRNAs that are the most downregulated in D492M and we are currently working on other miRNAs in these cell lines.
Oncogene-Induced EMT and Tumor Progression
When transplanted into nude mice D492HER2 cells formed large tumors. Interestingly D492EGFR/HER2 were not as tumorigenic as D492HER2. While all mice developed tumors, the growth was stunted compared to HER2 alone, indicating that EGFR has some growth suppressive properties in D492EGFR/HER2 (Fig. 4c). Incidentally, we observed that the HER2/EGFR tumors had high levels of epithelial cells, consistent with the 3D culture observations. We therefore postulated that EGFR enabled the HER2 overexpressing cells to maintain an epithelial phenotype, resulting in slower tumor growth. Finally, we treated D492HER2 tumor xenografted mice with either trastuzumab (monoclonal antibody against HER2), cetuximab (monoclonal antibody against EGFR) or combination of both for 20 days. As expected, treatment with trastuzumab reduced the volume of the D492HER2 tumors. Cetuximab resulted in growth arrest during treatment. Combination of trastuzumab and cetuximab also reduced the tumor volume initially but after end of treatment tumor growth resumed. Most interestingly, if the mice with the D492HER2 tumors were treated with cetuximab and trastuzumab, advanced growth was seen compared to treatment with trastuzumab alone, indicating that EGFR treatment in a HER2 driven environment could have detrimental effects (Fig. 4d) . Although, considered negative for EGFR based on immunostaining, D492HER2 cells were positive for phosphorylated EGFR when tested on western blot. Thus, these data indicate that EGFR expression may work as a tumor suppressor in the D492HER2 cells and combination treatment with both trastuzumab and cetuximab could actually override the effects achieved by treatment with trastuzumab alone.
D492HER2 cells show mesenchymal traits, but not as prominent as D492M. It is possible that partial EMT in D492HER2 renders the cells with increased cellular plasticity that further accelerates the tumor growth. In contrast D492M is more fixed in its mesenchymal state, possibly explaining its low tumorigenicity. In a recent review, Shibue et al. discussed cellular plasticity and EMT . Herein they argue that tumor cells were highly malignant if they were showing partial EMT but not if their phenotype was more into the mesenchymal differentiation . It is possible that partial EMT is reflecting cellular plasticity rather than true EMT and that these cells can change their phenotype in order to adapt better to new environments, which is necessary for cancer cell invasion and metastasis.
Concluding Remarks and Future Perspectives
Although animals (mainly mice) have contributed significantly to research on mammary gland morphogenesis and cancer it is of importance to acknowledge that there is a histological and biological difference between the mouse mammary gland and the human female breast that cannot be ignored. Data is accumulating that in the human breast the TDLU-associated stroma has a dominant role on branching morphogenesis. TDLU in addition to its milk producing function during lactation is the place where most breast cancers originate. In mice, there are no TDLUs, only terminal end buds and the stroma is mainly composed of fat tissue. If the stroma is dominant in bringing signals to the epithelium it is obvious that these signals are different between mice and humans. It is also important to acknowledge that cell culture is and will continue to be conducted in an artificial environment. However, using breast cells, both epithelial and stromal cells, and continuous improvement of cell culture environment will help to fill the gaps that exist between the mouse and the human mammary gland. There is no doubt that cell lines are important and will continue to be so in the near future. They are important tools but have their disadvantages that need to be taken into account when experiments are designed.
- 7.Fridriksdottir AJ, Villadsen R, Morsing M, Klitgaard MC, Kim J, Petersen OW, et al. Proof of region-specific multipotent progenitors in human breast epithelia. Proc Natl Acad Sci U S A. 2017;114(47):E10102–E10111. https://doi.org/10.1073/pnas.1714063114.
- 8.Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115:39–50.Google Scholar
- 16.Cardiff RD, Bern HA, Faulkin LJ, Daniel CW, Smith GH, Young LJ, et al. Contributions of mouse biology to breast cancer research. Comp Med. 2002;52:12–31.Google Scholar
- 20.Koledova Z. 3D cell culture: an introduction. Methods Mol Biol. 1612;2017:1–11.Google Scholar
- 25.Linnemann JR, Meixner LK, Miura H, Scheel CH. An organotypic 3D assay for primary human mammary epithelial cells that recapitulates branching morphogenesis. Methods Mol Biol. 1612;2017:125–37.Google Scholar
- 29.Anonymous. Matrigel®basement membrane matrix. Beckton Dickinson Technical letter 1995;7/95-CBP-GFRMATRIGEL.Google Scholar
- 30.Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105:223–35.Google Scholar
- 41.Brooks SC, Locke ER, Soule HD. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem. 1973;248:6251–3.Google Scholar
- 49.Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development. 2000;127:2269–82.Google Scholar
- 50.Sigurdsson V, Fridriksdottir AJ, Kjartansson J, Jonasson JG, Steinarsdottir M, Petersen OW, et al. Human breast microvascular endothelial cells retain phenotypic traits in long-term finite life span culture. In Vitro Cell Dev Biol Anim. 2006;42:332–40.Google Scholar
- 55.Moes M, Le Bechec A, Crespo I, Laurini C, Halavatyi A, Vetter G, et al. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One. 2012;7(4):e35440. https://doi.org/10.1371/journal.pone.0035440.
- 59.Ingthorsson S, Andersen K, Hilmarsdottir B, Maelandsmo GM, Magnusson MK, Gudjonsson T. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR. Oncogene. 2016;35(32):4244–55. https://doi.org/10.1038/onc.2015.489.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.